SYNCOR INTERNATIONAL CORP /DE/

SYNCOR INTERNATIONAL CORP /DE/, operating under CIK 202763, sits squarely in the Wholesale-Drugs, Proprietaries & Druggists’ Sundries SIC, distributing specialized drugstore inventory for pharmacies, hospitals, and other healthcare providers across regional and national chains. The company builds its reputation on reliably delivering branded and generic pharmaceuticals, over-the-counter remedies, and sundry healthcare essentials, coupled with tailored logistics and inventory management services that help customers maintain lean stock levels without compromising patient care. SYNCOR’s supply chain expertise and compliance programs aim to keep pace with FDA and DEA regulation, but the business remains sensitive to regulatory audits, drug shortages, pricing pressure, and shifts in payer reimbursement that could ripple through the wholesale-distribution segment. Investors and partners should watch the company’s disclosures, including the most recent Form 10-Q filed in November 1999, for indications about working capital, customer concentration, and inventory risk. View live SEC filings on Earnings Feed to stay current.

Source: Earnings Feed research · last updated 11/24/2025